ESG

A landmark study reveals 100% tumor control with a personalized radiation therapy, offering profound new hope for patients with inoperable liver cancer.

As women in midlife turn to drugs like Ozempic, a new crisis is emerging: significant muscle loss. A new approach aims to protect metabolic health.

With promising Phase 2 data for its novel peptide therapies, Sapience Therapeutics is engaging investors, signaling a critical push for future growth.

CHC: Creating Healthier Communities adds policy expert Edo Banach to its board, a strategic move to leverage his deep Medicare and Medicaid expertise.

Israel's parliament passes a major R&D tax overhaul, offering huge credits to counter global tax reforms and secure its 'Startup Nation' status.

With deep D.C. experience, Scott Dziengelski takes the helm at NABH, poised to tackle pressing issues like parity, workforce, and the addiction crisis.

A landmark deal aims to turn a manufacturing hub into a design capital, but can Guangzhou overcome the challenges of its rapid transformation?

A new transatlantic fund aims to bridge the biodiversity funding gap by investing in regenerative farms and forests, betting that healing nature can also yield profit.

Ditching the old OEM model for a 'win-win ecosystem,' Chery bets on shared tech and green manufacturing. A global summit will test this bold new vision.

Italian infrastructure giant Mundys can now own nearly 30% of Getlink, a key move in European transport that passed the UK's strict security review.

IVY Rx unveils its 2026 compounded GLP-1 program with clear pricing, but operates in a market facing intense FDA warnings and regulatory uncertainty.

The market for at-home NAD+ therapy is booming, but as telehealth offers new convenience, it faces a wave of regulatory and safety questions.

Replimune halts a promising cancer therapy and cuts jobs after a stunning FDA rejection, citing a 'failed' system and inconsistent regulatory process.

Diamondback Energy is buying back nearly $1 billion in long-term debt. What does this strategic financial move reveal about its future and the energy sector?

A Chicago jury found Abbott liable for infants' injuries from Similac, adding to a wave of lawsuits over the deadly intestinal disease NEC.

Gensler's Andy Cohen joins the REIT's board, signaling a strategic shift toward design-led development in LA and Honolulu's premium real estate markets.

After sweeping awards, 'The Ebony Canal' takes its powerful message on Black maternal health from Hollywood to a global stage, aiming for systemic change.

PureField Ingredients' new carbon capture project in Kansas could redefine sustainable food and fuel, promising economic boosts and a smaller carbon footprint.

Many Americans lack basic money skills, relying on friends or no one for advice. This April, experts highlight a growing crisis and the path to a solution.

A hidden danger in IV lines causes thousands of preventable deaths. Now, one company is showcasing a new strategy to protect patients from this 'gross gap'.